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Abstract
Heart failure is a major cause of morbidity and mortality whose costs impose staggering health-care costs and often lengthy
hospitalizations. Post-operative atrial fibrillation (POAF) represents a leading cause for heart failure, paricularly after cardiac
and lung surgeries. Although PAOF is a common cardiac arrhythmia, it is impossible to predict. As the worldwide population is aging, the incidence and prevalence of PAOF is growing. Identifying mechanisms for PAOF is attracting a considerable amount of research with no agreement on the mechanism(s). Our research on the heart and cardiovascular system, over
the past 50-plus years, leads us to believe that major causes of PAOF may be an underlying magnesium deficiency (MgD)
coupled to a generation/ release of ceramides and platelet-activating factor (PAF). Herein, we review reasons behind our
hypothesis and suggestions for testing its validity.

Keywords: PAF; Sphingolipids ; Heart Failure; Atherosclerosis; Inflammation.

Introduction
Post-operative atrial fibrillation (POAF) is the most prevalent
complication after cardiac or lung surgery, occurring in about
20-50 percent of these patients [1-5]. This event often leads to
increased morbidity, thromboembolisms, strokes and long-term
mortality resulting in recurring hospitalizations and increased
costs. Often the cause(s) of POAF is not known. Age, previous
history of atrial fibrillation (AF), hypertension, diabetes,
myocardial infarction, valvular heart disease, left ventricular
hypertrophy, obesity, excessive drinking of alcohol and excessive
smoking present great risk factors for development of POAF [15]. According to a number of reports, the incidence of cerebral
infarction and heart failure can increase two-four - fold after PAOF
[1-5]. Added to this, are a number of growing autopsy studies
which demonstrate that many of the PAOF patients, who have
died, have considerable atherosclerotic plaques on the walls of

the coronary vessels leading to the idea that inflammatory events
probably play an important role in the PAOF syndrome [5]. POAF
is usually managed by digoxin, calcium channel blockers, betablockers, quinidine, amiodarone, direct current cardioversion,
catheter ablation inside the heart, or appropriate rate control
techniques to restore rhythm to normal [1-5]. Although digoxin
is often utilized, it can present direct risks for POAF patients
and has been associated with increased hospitalizations and
mortalities [6, 7]. Such data has raised serious concerns about
use of digoxin, one of our oldest and most controversial drugs
. Ever since 1935 [8], digoxin and cardiac glycosides have been
known to deplete the human body and heart of magnesium (Mg)
[for review, see [9]]. Several studies have suggested that use of
intravenous magnesium sulfate may be better than either betablockers, calcium channel blockers, or amiodarone [1, 5, 10-12].
This concept is currently under investigation by several groups in
the USA and Europe.
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Why use intravenous Mg2+ ?
Mg is a co-factor for more than 500 enzymes, and is the second
most abundant intracellular cation after potassium. It is vital in
numerous physiological , cellular and biochemical functions
necessary for life [for reviews, see [13-15]].
Approximately 35 years ago, our laboratory suggested a
progressive, dietary deficiency and/or metabolic-induced loss of
Mg from the body (and heart), particularly during development
of coronary arteries, could lead to coronary arterial vasospasm,
arrhythmias, and sudden-cardiac death [16, 17]. Ever since this
work was published, a number of clinical studies have been
done and published which support this hypothesis, at least
in adults [18-23]. Disturbances in diet are known to produce
inflammatory lesions, promote lipid deposition and accelerated
growth, and transformation of the smooth muscle cells in the
vascular walls [9, 13, 14, 24-28]. Reduction in dietary Mg intake
has been demonstrated , experimentally, to result in atherogenesis,
hypertension, cardiac dysfunctions, inflammations, and stroke
of different types [9, 13-15, 29-33]; most of these phenomena
usually being observed in patients scheduled for cardiac and lung
surgeries. Hypermagnesemic diets have been shown to ameliorate
atherogenesis, hypertension, cardiac dysfunctions, strokes and
certain inflammatory conditions often found in patients scheduled
for cardiac and lung surgeries [9, 13, 14, 24, 27-33]. In the Western
World, dietary intake of Mg is subnormal, with shortfalls of
between 65 and 225 mg of Mg/day, depending upon geographic
region [9, 13-15, 30, 34, 35]. Newly compiled NHANES data
indicate that approximately 65% of the American population is Mg
deficient [36]. Low Mg content in drinking water, found in areas
of soft water and Mg-poor soil, is associated with high incidences
of ischemic heart disease (IHD), severe atherosclerosis, coronary
vasospasm, hypertension, hyperlipidemia, and sudden-cardiac
death [37- 44]. The myocardial level of Mg has consistently been
observed to be lower in subjects dying from IHD and suddencardiac death in soft water areas [9, 13, 16, 17, 24, 39, 43].
Using sensitive, specific Mg2+- ion electrodes, it has been shown
that patients with IHD, patients scheduled for cardiac surgery or
lung surgery, patients in cardiac failure, and patients with severe
atherosclerosis exhibit significant depletion of serum/plasma and
tissue levels of ionized, but not usually total Mg [15, 27, 33, 4565]. Moreover, dietary deficiency of Mg, under very controlled
laboratory conditions, in rats and rabbits has been shown to
cause vascular remodeling concomitant with atherogenesis and
hypertension (e.g., arteriolar wall hypertrophy and alterations in
arterial wall matrices) of unknown origin [67-69].

Mg2+ modulates sphingolipid pathways in cardiac
and vascular smooth muscle cells
Although Mg depletion has long been known to result in cellular
Ca2+-overload in cardiac and vascular smooth muscles (VSM) [7073], and Mg can act as a natural Ca2+ channel blocker [71-73],
recent studies indicate that Mg2+ modulates sphingolipid pathways
in both cardiac and VSM cells [27, 43, 44, 74-86]. Ceramides
are sphingolipids known to be released as a consequence of
sphingomyelinase (SMase) acting on sphingomyelin (SM), a
component of all cell membranes, or as a consequence of the
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activation of serine palmitoyl transferase 1 and 2 (SPT 1 and
SPT 2) (a de novo synthetic pathway) [87]. Ceramides are now
thought to play important roles in fundamental processes such
as inflammation, angiogenesis, membrane-receptor functions,
cell proliferation, microcirculatory functions, cell adhesion,
immunogenic responses, excitation-contraction coupling events
in smooth muscles, and cell death (i.e., apoptosis) [27, 43, 44,
74-92]. SPT 1 and SPT 2 are the rate-limiting enzymes in the
biosynthesis of sphingolipids [87]. More than 25 years ago, it was
first demonstrated that SPT activity was increased in aortas of
rabbits fed a high-cholesterol diet [93]. A short time after these
latter studies were published, two of us showed that dietary
deficiency of Mg, in levels found commonly in Western World
diets, vastly increased atherosclerotic plaque formations in rabbits
fed high -cholesterol diets, whereas high dietary levels of Mg
inhibited plaque formations [28]. SPT is a hetrodimer of 53-kDa
SPT-1 and 63-kDa SPT-2 subunits [87], both of which are bound
to the endoplasmic reticulum [94]. An upregulation of SPT has
been hypothesized to play a role in apoptosis, cell death events
taking place in atherogenesis [79, 95].
Recently, we reported that Mg deficient (MgD) diets given to
rats for only 21 days results in upregulation of SMases (i.e.,
N-SMase, acid--SMase, and alkaline SMase), ceramide synthase,
sphingomyelin synthase, SPT-1 and SPT-2 in a variety of
cardiovascular tissues and cells as well decreased levels of SM and
phosphatidylcholine (PC) [79-82, 84-86]. We also noted that MgD
diets resulted in fragmentation of DNA [81, 86, 96], release/
generation of a number of cytokines (and chemokines) [84], a
release of cytochrome C [80] and lactic acid dehydrogenase [82],
an increased expression of apototic protease factor-1 [81, 84], an
activation of caspase-3 ( needed for cell death) [79], all hallmarks
of atherogenesis. When specific inhibitors of the SMases and
SPT-1 (and SPT-2) were utilized, in primary cell cultures of
VSM cells (including those from coronary arteries), exposed
to low Mg2+ environments, we noted an inhibition and release
of ceramides, inhibition of DNA fragmentation, inhibition
of release of cytochrome C from the mitochondria, reduced
expression of protease factor-1, an inhibition of activation of
caspase-3, a decreased release of lactic acid dehydrogenase from
the heart, reduced lipid peroxidation of cardiac muscle cells, and
attenuation of release/generation of cytokines and chemokines
[79-82, 84-86, 96, 97]. Working with perfused rat hearts, our
laboratories found that low Mg2+ environments caused decreased
perfusion pressures, decreases in stroke volume, marked decreases
in coronary arterial flows, decreases in cardiac output, generation
of ceramides, reductions in cardiac cellular ATP, phosphocreatine
and pH [98] and generation of reactive oxygen species [99].
We, thus, believe that , collectively, these new studies on hearts
and coronary arteries from animals on MgD diets support our
hypothesis that generation and release of ceramides are pivotal
molecules in the initiation of cellular and molecular events leading
to coronary arterial (and coronary microcirculatory) ischemic
changes, eventuating in inflammatory and atherogenic events
producing atrial arrythmias and fibrillation.
During the performance of the foregoing in-vivo and in-vitro
studies , using proton- nuclear magnetic resonance spectroscopy,
we noted rapid formation of platelet-activating factor (PAF) and
PAF-like lipid molecules [74].
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Magnesium deficient environments lead to formation of PAF and its potential significance to atrial
fibrillatory events
PAF is known to play major roles in inflammatory responses and
atherogenesis [for reviews, see [100-102]]. In addition, PAF is
known to affect the heart and cardiac muscle cells in numerous
ways [for reviews, see [101, 102]]. For example, PAF can produce
coronary arterial vasoconstriction, lower arterial blood pressure,
increase coronary vascular resistance, release several lipid-like
molecules from the heart, reduce cardiac output, decrease cardiac
contractility, alter atrial and papillary muscle chronotropicity and
membrane action potentials, as well as alter potassium currents in
isolated cardiomyocytes [for reviews, see [101, 102, 103]]. All of
these attributes of PAF's actions on the heart and coronary vascular
tree certainly would be more than enough to cause profound atrial
fibrillation. Moreover, a variety of the circulating blood formed
elements (e.g., polymorph nuclear leukocytes, platelets, basophils,
and macrophages) and endothelial cells can elaborate PAF [101,
102]. Recently, we have found that coronary, cerebral and aortic
VSM cells can also elaborate and release PAF [103]. There are a
growing number of reports that both PAF and ceramides may result
in transformation of VSM cells from one phenotype to another,
as is typically found in the atherosclerotic process [for reviews,
see [103-106]]. A number of investigators employing intravital
microscopy techniques, similar to those used in our laboratories
[for review, see [103]] have demonstrated that PAF increased the
number of white blood cells in the microvessels concomitant with
intense vasoconstriction-spasms with increasing concentrations
of the putative lipid mediator (i.e., PAF), less leukocyte rolling
, and increased adherence of the leukocytes to the endothelial
surfaces with increased vascular-capillary permeability [for review,
see [103]]. Using open and closed chambers implanted in rodent
cerebral cortex and skeletal muscles, we have observed similar
phenomena [103]. Interestingly, we have reported that ceramides
produce almost similar phenomena in a variety of microvascular
beds when studied by high-resolution video microscopy [78, 103].
Collectively, these older and newer experimental studies could be
used to advance our hypothesis that generation and release of
both PAF and ceramides with underlying MgD states are more
than likely involved in generation of atrial fibrillation after cardiac
and lung surgery and may be major contributors in other types of
patients presenting with atrial fibrillation.

Importance of Mg supplemented drinking water
and beverages for heart health
Over the past two-plus decades, our laboratories have been
investigating the utility of Mg-supplemented or naturallyoccurring spring waters to avoid the pitfalls of dietary-and/
or metabolically-induced MgD-states which affect heart health
[e.g., see [79-82, 84-86, 96, 97]. Our results, so far, bolster the
idea that water intake (e.g., from tap waters, well waters, bottled
waters, beverages using tap/well/spring waters, or desalinated
waters) in humans should contain at least 25-40 mg/liter/day of
Mg2+ [107]. A number of experiments done in our labs indicate
that most, if not all of the cardiovascular manifestations (i.e.,
decreased cardiac output, decreased coronary arterial flows, lipid
peroxidation of cardiac muscle membranes, synthesis/release of
toxic sphingolipids, cytokines and chemokines, mitochondrial
release of cytochrome C, increased Ca2+ entry and overload,
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apoptosis, etc) observed in hearts of experimental animals can
be prevented or ameliorated when imbibing drinking waters with
appropriate amounts of Mg2+ [79-82, 84-86, 96, 97]. We believe
the latter inclusion in our diets should go a long-way towards the
prevention and amelioration of heart arrthymias and fibrillations
. Instituting such a daily regimen should also prevent a number
of underlying risk factors for PAOF (e.g., drinking of alcoholic
beverages, excessive smoking, and aging). Interestingly, on the
basis of our work in animals, the World Health Organization has
suggested people should consume drinking waters containing
our recommended 25-40 mg/liter/day of Mg2+ [108]. It is our
hope that a large scale appropriately-controlled clinical trial can
be instituted in patients scheduled for cardiac and lung surgeries
to test our hypothesis.

Future considerations
Although the exact underlying cause(s) of the high frequency of
PAOF in patients scheduled for heart or lung surgeries remains to
be determined, a number of animal models ( in mice, goats, rabbits
and dogs) have been utilized to gain insights into possible causes
of atrial fibrillation (AF) [for reviews, see [2, 4, 5]]. A number of
these models have employed knock-out and knock-down mice for
several potential target genes . Several of these mouse AF models
could be examined to determine if they are MgD (particularly
decreased ionized Mg levels) and have excess PAF and ceramide
synthesis and release as a test of our hypothesis. In addition, a
clinical study should be undertaken to determine ionized Mg
levels, ceramide levels, and PAF levels prior to and after cardiac
and lung surgeries to examine any correlations between these
parameters before (and after surgeries) to frequency of PAOF.
Moreover, it would be prudent, we believe, to undertake clinical
blinded- trials to determine whether pretreatment of patients,
scheduled for cardiac or lung surgery, would benefit from
pretreatment with selective blockers of ceramide generation/
release and PAF generation/release along with administration of
oral and intravenous Mg. Only time will tell whether these human
and animal studies will prove to validate our hypothesis.
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